Open AccessThe Evaluation of Patients with Severe COVID-19 Pneumonia Who are Recieving Favipiravir Treatment
Author(s) -
Servet Öztürk,
Onur Çolak,
Semra Toprak Kavas,
Derya Öztürk-Engin,
Serap DİKTAŞ TAHTASAKAL,
Dilek Erdoğan Arı,
Öznur DEMİROLUK,
Berna ÖZDEMİR,
Büşra Meral Çetinkaya,
Merve Kaçar Eker,
İrem Asena Doğan,
Haluk Vahaboğlu,
Canan Ağalar
Publication year - 2021
Publication title -
mediterranean journal of infection microbes and antimicrobials
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.121
H-Index - 1
ISSN - 2147-673X
DOI - 10.4274/mjima.galenos.2021.2020.22
Subject(s) - medicine , pneumonia , mortality rate , methylprednisolone , respiratory distress , severity of illness , retrospective cohort study , favipiravir , ards , pediatrics , covid-19 , surgery , disease , lung , infectious disease (medical specialty)
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom